PDCD1 and lymphoma: For lymphoma patients, different interesting target could be considered for iPET, such as general T cell markers (CD3, CD4, and CD8), immune-checkpoints (PD-1, PD-L1 or CTLA-4) or biomarkers of the immune response (interferon-gamma, interleukin-2, and granzyme B) [12].